CRKL and ovarian carcinoma: Elevated expression of CrkL in cancer tissues also has been shown to lead to poor prognosis and lower survival of patients with NSCLC [32], ovarian cancer [65], gastric [63], pancreatic ductal adenocarcinoma [73], and colorectal cancer [40].